2020 Drugs Licensing 
New Drug Approvals
JULY 25, 2025
The distinction between it and traditional corticosteroid drugs lies in its capacity to specifically activate particular signaling pathways of corticosteroids. In individuals diagnosed with DMD, the primary mechanism through which corticosteroid drugs exhibit their effectiveness is by exerting anti-inflammatory effects. 70) Keam, S.
DrugBank
JUNE 18, 2025
Drug development is a complex and highly regulated process. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other global counterparts, set rigorous standards to ensure that drugs are safe, effective, and high-quality. Regulatory agencies, such as the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
New Drug Approvals
APRIL 25, 2025
12] However, absorption, metabolism, and excretion data of taselisib , a molecule with a related chemical scaffold, suggest moderately slow absorption into the systemic circulation, metabolism to play a minor role in drug clearance, and biliary excretion to be the main route of excretion. [13] Food and Drug Administration (FDA).
New Drug Approvals
MAY 9, 2025
Food and Drug Administration (FDA). “RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models” Anti-Cancer Drugs. 1] [4] It is taken by mouth. [1] 3] [7] PATENTS Cruskie MP, et al. Retrieved 11 February 2023. 27 January 2023.
Drug Target Review
JULY 29, 2025
Effective financial management is a cornerstone in the success of clinical trials, which are integral to the advancement of drug discovery. This led her to found Condor Software in 2020, a company focused on providing cloud-based solutions that integrate financial operations with clinical trials. Available from: [link]
New Drug Approvals
JUNE 15, 2025
Retrieved 15 September 2024. ^ “Notice: Multiple additions to the Prescription Drug List (PDL) [2024-08-13]” Health Canada. Retrieved 15 August 2024. ^ “Regulatory Decision Summary for Zilbrysq” Drug and Health Products Portal. Food and Drug Administration (FDA). Food and Drug Administration (FDA).
New Drug Approvals
JUNE 29, 2025
2020/0062765) was dissolved in ethanol (604 mL) at 50℃. 3] The US Food and Drug Administration (FDA) granted the application for taletrectinib priority review , breakthrough therapy , and orphan drug designations. [3] Food and Drug Administration. Food and Drug Administration (FDA). Application Publication No.
Expert insights. Personalized for you.
Let's personalize your content